SCHEMBL14907874

SCHEMBL14907874

Nc1ccc2c3c1C(=O)OC3(O)c1ccccc1C2=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 1/20 1.00
MAOA P21397 2/20 0.45
MAOB P27338 1/20 0.45
ADORA2A P29274 4/20 0.44
CSNK1A1 P48729 2/20 0.43
CSNK1D P48730 2/20 0.43
CSNK1G1 Q9HCP0 2/20 0.43
FGR P09769 1/20 0.43
PIM1 P11309 1/20 0.43
DYRK1A Q13627 1/20 0.43
HIPK2 Q9H2X6 1/20 0.43
POLB P06746 6/20 0.41
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
TDP1 Q9NUW8 3/20 0.41
MCL1 Q07820 2/20 0.41
PABPC1 P11940 1/20 0.41
HPGD P15428 1/20 0.41
BLM P54132 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1867008 0.68 GRK6 (0.51) GRK6MAOAADORA2ACSNK1A1CSNK1D
SCHEMBL11482321 0.66 MEN1 (0.48) GRK6MAOAPOLBMEN1KMT2A
SCHEMBL9861501 0.65 PDK2 (0.54) GRK6MAOAADORA2ACSNK1A1CSNK1D
SCHEMBL1612506 0.64 GRK6 (0.46) GRK6MAOAMAOBADORA2ACSNK1A1
SCHEMBL9100605 0.64 CFTR (0.61) GRK6POLBMEN1KMT2ASMN1; SMN2
SCHEMBL487001 0.63 MAOA (1.00) GRK6MAOAMAOBADORA2ACSNK1A1
SCHEMBL30129869 0.63 MAOA (1.00) GRK6MAOAMAOBADORA2ACSNK1A1
SCHEMBL21840830 0.63 ADORA2A (0.78) GRK6MAOAMAOBADORA2ACSNK1A1
SCHEMBL525762 0.63 ADORA2A (1.00) GRK6MAOAMAOBADORA2ACSNK1A1
SCHEMBL29361319 0.63 ADORA2A (1.00) GRK6MAOAMAOBADORA2ACSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2019-04-09 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
WO-2013063458-A2 INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides GRK6, GRK2, GRK3 GRK6 1/4885MAOA 3941/4885MAOB 3601/4885
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides GRK6, GRK2, GRK3 GRK6 1/4885MAOA 3941/4885MAOB 3601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.